SEARCH
Australia’s listed investment company (LIC) pipeline is set to grow with the launch of several more companies slated for this year, according to Independent Investment Research.
In its monthly LIC wrap, Independent Investment Research (IIR) noted that three managers – Investors Mutual Limited, Antipodes Partners, and H2 Ventures – are all launching new LICs.
H2Ocean, managed my H2 Ventures and which invests in fintech start-ups, is one of these LICs and IIR notes the company is looking to raise between $27.5 million and $55 million in its IPO. Shares are expected to commence trading on the ASX in October.
Both the Investors Mutual and Antipodes Partners LICs – the QV Income fund and the Antipodes Global Investment Company respectively – are looking to raise around $300 million with their IPOs.
The IPO of the Antipodes Global Investment Company, which will invest in a global long/short strategy, is expected to close on 30 September, IIR said.
Investors Mutual is yet to lodge a prospectus with the ASX, although IIR said this is expected to happen in October.
Read more:
Australian Unity adds SMAs to platform
Equity Trustees appointed as RE
Hedge fund fees are 'too high': AQR
Westpac refunds $9.2m in account fees
Demand for global equity products rising: Lonsec
Stimulate new ideas. Stimulate new thinking. Top up your CPD and hear from industry experts with InvestorDaily’s Knowledge Centre. Keep up to date with the latest trends and reforms, all while adding to your CPD. Explore the knowledge centre Knowledge Centre now.
The investment management group has downplayed its profit expectations ahead of reporting season but says it is “continuing to build on st...
Despite unemployment falling to pre-pandemic levels, the central bank still thinks it’s too early to count its chickens on the success of ...
The US Federal Reserve has taken its first steps towards raising interest rates as the domestic economy powers ahead in COVID recovery mode,...
Get notifications in real-time for staying up to date with content that matters to you.
Read More
